• Mashup Score: 0

    We are grateful to these distinguished faculty who contributed to this collection: Michael D. Shapiro, DO, FACC (Chair) Charles German, MD, MS Christie M. Ballantyne, MD, FACC Pam Taub, MD, FACC  Raul D. Santos MD, PhD, MSc Salim S. Virani, MD, FACC Sarah de Ferranti MD, MPH

    Tweet Tweets with this article
    • Join our expert faculty for a quick tip 📽️ on how to diagnose HoFH, screen for #FH & manage HoFH in children & adolescents. Find more resources for improving detection & diagnosis of FH w/ #ACCEd. Learn more 👉 https://t.co/bPzupFYxpz #KnowFH #CardioTwitter https://t.co/gpSqUQrAvc

  • Mashup Score: 5

    Amgen performed very effectively in 2022, reaching roughly 10 million patients around the world with our approved medicines, advancing many promising new medicines, delivering strong financial performance, and keeping the Company on track to achieve attractive growth through the end of the decade.

    Tweet Tweets with this article
    • Everyone deserves to understand what their cardiovascular health risks are and have the chance to protect it. Thank you @amgen for your commitment to winning the fight against cardiovascular disease. Read more: https://t.co/kMEOy26vaG #KnowFH #KnowLpa #LDLSafeZone https://t.co/vm3pO0rcls

  • Mashup Score: 2

    Familial hypercholesterolemia (FH) is one of the most prevalent forms of genetic dyslipidemias with an estimated prevalence of ∼1/300 worldwide,1,2 but with considerable variability in some populations.3,4 FH is an autosomal co-dominant genetic disease associated with extremely elevated low-density lipoprotein cholesterol (LDL-C) (>95th percentile for age and sex) and premature atherosclerotic…

    Tweet Tweets with this article
    • Recent @LipidJournal publication ➡️ Prevalence of metabolic syndrome (MetS) in a multinational cohort of #KnowFH Patients was 14% & was associated with a 2-fold ⤴️‘ed risk of incident ASCVD & a 4.9-fold ⤴️’ed risk of mortality. https://t.co/gEu1rOlSvw Fig. shows ASCVD event rates https://t.co/rokjXBmmn7 https://t.co/pKOCNb1Hat

  • Mashup Score: 0

    Familial hypercholesterolemia (FH) is one of the most prevalent forms of genetic dyslipidemias with an estimated prevalence of ∼1/300 worldwide,1,2 but with considerable variability in some populations.3,4 FH is an autosomal co-dominant genetic disease associated with extremely elevated low-density lipoprotein cholesterol (LDL-C) (>95th percentile for age and sex) and premature atherosclerotic…

    Tweet Tweets with this article
    • Recent @LipidJournal publication ➡️ Prevalence of metabolic syndrome (MetS) in a multinational cohort of #KnowFH Patients was 14% & was associated with a 2-fold ⤴️‘ed risk of incident ASCVD & a 4.9-fold ⤴️’ed risk of mortality. https://t.co/gEu1rOmql4 Fig shows 10 yr ASCVD events https://t.co/CNMJHZ6NrO

  • Mashup Score: 0

    Weekly news , posts and updates for Lipidology & Cardiovascular Disease Prevention by Dr. James Underberg

    Tweet Tweets with this article
    • The latest LipidDoc's Daily is out !! https://t.co/HMZzX73xUB Thanks to @nationallipid @TheFHFoundation @ACCinTouch #knowfh #wccardio

  • Mashup Score: 0

    Weekly news , posts and updates for Lipidology & Cardiovascular Disease Prevention by Dr. James Underberg

    Tweet Tweets with this article
    • The latest LipidDoc's Daily is out !! https://t.co/f5IKwgXKEZ Thanks to @Lpa_Doc @nationallipid @TheFHFoundation #knowfh #knowlpa

  • Mashup Score: 1
    Wolters Kluwer Health - 1 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Does LDL fully explain the ❤️‍🩹 atherosclerotic risk associated with familial hypercholesterolemia 🧬 genetic variants? Yes! But... #KnowFH #cholesterol https://t.co/A7xkDKUgO7 https://t.co/okX0jWdBOD